S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself
S&P 500   4,550.58
DOW   35,430.42
QQQ   389.81
How to trade penny stocks: A step-by-step guide
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
These are the top sectors for blue chip growth in 2024
MercadoLibre up 28% as Latin American ecommerce poised for growth
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
J&J, Gilead, BMS: A look at undervalued dividend payers
The 4 highest-shorted large-cap stocks
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
The JD.com train is getting ready to leave the station again
3 stocking stuffers you can buy for yourself

Align Technology Stock Price, News & Analysis (NASDAQ:ALGN)

$216.48
+2.34 (+1.09%)
(As of 11/29/2023 ET)
Compare
Today's Range
$215.94
$221.65
50-Day Range
$183.21
$307.51
52-Week Range
$176.34
$413.20
Volume
1.12 million shs
Average Volume
894,834 shs
Market Capitalization
$16.58 billion
P/E Ratio
45.86
Dividend Yield
N/A
Price Target
$336.60

Align Technology MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.70 Rating Score
Upside/​Downside
55.5% Upside
$336.60 Price Target
Short Interest
Healthy
4.10% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.34
Upright™ Environmental Score
News Sentiment
0.96mentions of Align Technology in the last 14 days
Based on 2 Articles This Week
Insider Trading
Acquiring Shares
$2 M Bought Last Quarter
Proj. Earnings Growth
12.66%
From $6.87 to $7.74 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.29 out of 5 stars

Medical Sector

9th out of 949 stocks

Surgical Appliances & Supplies Industry

1st out of 20 stocks


ALGN stock logo

About Align Technology Stock (NASDAQ:ALGN)

Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, China, and internationally. It operates in two segments, Clear Aligner; and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; and non-case products that include retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment. The Systems and Services segment offers iTero intraoral scanning system, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, and pay per scan services Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

ALGN Stock Price History

ALGN Stock News Headlines

Bargain alert: 3 large caps with RSIs that scream oversold
With a risk-on sentiment returning, it's a great time to see what stocks were perhaps beaten down more than they deserved and if any are still oversold
Bargain alert: 3 large caps with RSIs that scream oversold (ALGN)
With a risk-on sentiment returning, it's a great time to see what stocks were perhaps beaten down more than they deserved and if any are still oversold
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Align Technology To Repurchase $100 Mln Of Common Stock - Quick Facts
Align Technology To Repurchase $250 Mln Shares
Align Technology: Investors Were Not Aligned
Align Technology stock drops on 3Q miss; disappointing outlook
Align Technology's Price Plunge Is Jaw Dropping
See More Headlines
Receive ALGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Align Technology and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/25/2023
Today
11/29/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/07/2024

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:ALGN
CUSIP
01625510
Employees
23,165
Year Founded
1997

Price Target and Rating

Average Stock Price Target
$336.60
High Stock Price Target
$450.00
Low Stock Price Target
$200.00
Potential Upside/Downside
+55.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.70
Research Coverage
10 Analysts

Profitability

Net Income
$361.57 million
Pretax Margin
15.33%

Debt

Sales & Book Value

Annual Sales
$3.73 billion
Cash Flow
$7.68 per share
Book Value
$49.64 per share

Miscellaneous

Free Float
76,038,000
Market Cap
$16.58 billion
Optionable
Optionable
Beta
1.58

Social Links

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report














ALGN Stock Analysis - Frequently Asked Questions

Should I buy or sell Align Technology stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Align Technology in the last twelve months. There are currently 3 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" ALGN shares.
View ALGN analyst ratings
or view top-rated stocks.

What is Align Technology's stock price target for 2024?

10 Wall Street research analysts have issued 1 year price targets for Align Technology's shares. Their ALGN share price targets range from $200.00 to $450.00. On average, they expect the company's share price to reach $336.60 in the next twelve months. This suggests a possible upside of 55.5% from the stock's current price.
View analysts price targets for ALGN
or view top-rated stocks among Wall Street analysts.

How have ALGN shares performed in 2023?

Align Technology's stock was trading at $210.90 at the beginning of 2023. Since then, ALGN shares have increased by 2.6% and is now trading at $216.48.
View the best growth stocks for 2023 here
.

Are investors shorting Align Technology?

Align Technology saw a decline in short interest in the month of November. As of November 15th, there was short interest totaling 2,940,000 shares, a decline of 16.7% from the October 31st total of 3,530,000 shares. Based on an average daily trading volume, of 983,900 shares, the short-interest ratio is currently 3.0 days. Currently, 4.1% of the shares of the stock are sold short.
View Align Technology's Short Interest
.

When is Align Technology's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 7th 2024.
View our ALGN earnings forecast
.

How were Align Technology's earnings last quarter?

Align Technology, Inc. (NASDAQ:ALGN) announced its quarterly earnings data on Wednesday, October, 25th. The medical equipment provider reported $1.62 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.86 by $0.24. The medical equipment provider had revenue of $960.21 million for the quarter, compared to analyst estimates of $994.60 million. Align Technology had a trailing twelve-month return on equity of 12.66% and a net margin of 9.53%.

What is Joe Hogan's approval rating as Align Technology's CEO?

346 employees have rated Align Technology Chief Executive Officer Joe Hogan on Glassdoor.com. Joe Hogan has an approval rating of 97% among the company's employees. This puts Joe Hogan in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Align Technology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Align Technology investors own include NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), PayPal (PYPL), Micron Technology (MU), Adobe (ADBE), Visa (V), Salesforce (CRM), Mastercard (MA) and Tesla (TSLA).

Who are Align Technology's major shareholders?

Align Technology's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Polen Capital Management LLC (2.02%), Sands Capital Management LLC (2.00%), Bank of New York Mellon Corp (1.61%), Brown Advisory Inc. (1.39%), Morgan Stanley (1.33%) and Rhenman & Partners Asset Management AB (1.31%). Insiders that own company stock include C Raymond Larkin Jr, C Raymond Larkin, Jr, Emory Wright, George J Morrow, John Morici, Joseph M Hogan, Julie Ann Coletti, Kevin C Burns, Kevin J Dallas, Robert E Fitzgerald, Stuart A Hockridge, Thomas M Prescott and Warren S Thaler.
View institutional ownership trends
.

How do I buy shares of Align Technology?

Shares of ALGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

Does Align Technology have any subsidiaries?
The following companies are subsidiares of Align Technology: Align Technology Switzerland GmbH, Cadent, G.L. Dental Couture, and exocad Global Holdings GmbH (“exocad”).
Read More
This page (NASDAQ:ALGN) was last updated on 11/30/2023 by MarketBeat.com Staff

My Account -